• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3,5-二碘-L-甲状腺原氨酸在肝脂肪变性模型中改变脂滴组成。

3,5-diiodo-L-thyronine modifies the lipid droplet composition in a model of hepatosteatosis.

作者信息

Grasselli Elena, Voci Adriana, Canesi Laura, Salis Annalisa, Damonte Gianluca, Compalati Andrea D, Goglia Fernando, Gallo Gabriella, Vergani Laura

机构信息

Dipartimento di Scienze della Terra, dell'Ambiente e della Vita, Università degli Studi di Genova, Genova, Italy.

出版信息

Cell Physiol Biochem. 2014;33(2):344-56. doi: 10.1159/000356674. Epub 2014 Feb 5.

DOI:10.1159/000356674
PMID:24525903
Abstract

BACKGROUND/AIMS: Fatty acids are the main energy stores and the major membrane components of the cells. In the hepatocyte, fatty acids are esterified to triacylglycerols (TAGs) and stored in lipid droplets (LDs). The lipid lowering action of 3,5-diiodo-L-thyronine (T2) on an in vitro model of hepatosteatosis was investigated in terms of fatty acid and protein content of LDs, lipid oxidation and secretion.

METHODS

FaO cells were exposed to oleate/palmitate, then treated with T2.

RESULTS

T2 reduced number and size of LDs, and modified their acyl composition by decreasing the content of saturated (SFA) vs monounsaturated (MUFA) fatty acids thus reversing the SFA/MUFA ratio. The expression of the LD-associated proteins adipose differentiation-related protein (ADRP), oxidative tissue-enriched PAT protein (OXPAT), and adipose triglyceride lipase (ATGL) was increased in 'steatotic' cells and further up-regulated by T2. Moreover, T2 stimulated the mitochondrial oxidation by up-regulating carnitine-palmitoyl-transferase (CPT1), uncoupling protein 2 (UCP2) and very long-chain acyl-coenzyme A dehydrogenase (VLCAD).

CONCLUSIONS

T2 leads to mobilization of TAGs from LDs and stimulates mitochondrial oxidative metabolism of fatty acids, in particular of SFAs, and thus enriches of MUFAs the LDs. This action may protect the hepatocyte from excess of SFAs that are more toxic than MUFAs.

摘要

背景/目的:脂肪酸是细胞的主要能量储存形式和主要膜成分。在肝细胞中,脂肪酸被酯化为三酰甘油(TAGs)并储存在脂滴(LDs)中。从脂滴的脂肪酸和蛋白质含量、脂质氧化及分泌方面,研究了3,5-二碘-L-甲状腺原氨酸(T2)对肝脂肪变性体外模型的降脂作用。

方法

将FaO细胞暴露于油酸/棕榈酸,然后用T2处理。

结果

T2减少了脂滴的数量和大小,并通过降低饱和脂肪酸(SFA)与单不饱和脂肪酸(MUFA)的含量改变了其酰基组成,从而逆转了SFA/MUFA比值。在“脂肪变性”细胞中,与脂滴相关的蛋白质脂肪分化相关蛋白(ADRP)、富含氧化组织的PAT蛋白(OXPAT)和脂肪甘油三酯脂肪酶(ATGL)的表达增加,并被T2进一步上调。此外,T2通过上调肉碱-棕榈酰转移酶(CPT1)、解偶联蛋白2(UCP2)和极长链酰基辅酶A脱氢酶(VLCAD)刺激线粒体氧化。

结论

T2导致脂滴中TAGs的动员,并刺激脂肪酸尤其是SFA的线粒体氧化代谢,从而使脂滴中富含MUFA。这种作用可能保护肝细胞免受比MUFA毒性更大的SFA过量的影响。

相似文献

1
3,5-diiodo-L-thyronine modifies the lipid droplet composition in a model of hepatosteatosis.3,5-二碘-L-甲状腺原氨酸在肝脂肪变性模型中改变脂滴组成。
Cell Physiol Biochem. 2014;33(2):344-56. doi: 10.1159/000356674. Epub 2014 Feb 5.
2
3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver.3,5-二碘-L-甲状腺素可调节脂肪肝大鼠模型中脂质代谢基因的表达。
J Endocrinol. 2012 Feb;212(2):149-58. doi: 10.1530/JOE-11-0288. Epub 2011 Nov 22.
3
A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.脂质滴代谢的统一数学模型揭示了肝脂肪变性发展中的关键分子参与者。
FEBS J. 2017 Oct;284(19):3245-3261. doi: 10.1111/febs.14189. Epub 2017 Sep 6.
4
Acute administration of 3,5-diiodo-L-thyronine to hypothyroid rats stimulates bioenergetic parameters in liver mitochondria.对甲状腺功能减退的大鼠急性给予3,5-二碘-L-甲状腺原氨酸可刺激肝线粒体中的生物能量参数。
J Bioenerg Biomembr. 2016 Oct;48(5):521-529. doi: 10.1007/s10863-016-9686-4. Epub 2016 Nov 17.
5
3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet.3,5-二碘-L-甲状腺原氨酸通过调节线粒体功能,逆转高脂饮食喂养大鼠的肝脏脂肪堆积。
J Hepatol. 2009 Aug;51(2):363-70. doi: 10.1016/j.jhep.2009.03.023. Epub 2009 May 3.
6
PAT protein mRNA expression in primary rat hepatocytes: Effects of exposure to fatty acids.PAT 蛋白 mRNA 在原代大鼠肝细胞中的表达:脂肪酸暴露的影响。
Int J Mol Med. 2010 Apr;25(4):505-12. doi: 10.3892/ijmm_00000370.
7
Triglyceride Mobilization from Lipid Droplets Sustains the Anti-Steatotic Action of Iodothyronines in Cultured Rat Hepatocytes.脂质滴中甘油三酯的动员维持了碘甲状腺原氨酸在培养大鼠肝细胞中的抗脂肪变性作用。
Front Physiol. 2016 Jan 12;6:418. doi: 10.3389/fphys.2015.00418. eCollection 2015.
8
Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells.棕榈酸酯和棕榈油酸酯对大鼠L6骨骼肌细胞胰岛素作用及葡萄糖利用的不同影响。
Biochem J. 2006 Nov 1;399(3):473-81. doi: 10.1042/BJ20060244.
9
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats.3,5-二碘-L-甲状腺原氨酸通过增加脂肪燃烧,显著降低大鼠的肥胖程度。
FASEB J. 2005 Sep;19(11):1552-4. doi: 10.1096/fj.05-3977fje. Epub 2005 Jul 12.
10
OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.OXPAT/PAT-1是一种由过氧化物酶体增殖物激活受体(PPAR)诱导产生的脂滴蛋白,可促进脂肪酸的利用。
Diabetes. 2006 Dec;55(12):3418-28. doi: 10.2337/db06-0399.

引用本文的文献

1
Uncovering Actions of Type 3 Deiodinase in the Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).揭示 3 型脱碘酶在代谢相关脂肪性肝病(MAFLD)中的作用。
Cells. 2023 Mar 27;12(7):1022. doi: 10.3390/cells12071022.
2
Influence of Altered Thyroid Hormone Mechanisms in the Progression of Metabolic Dysfunction Associated with Fatty Liver Disease (MAFLD): A Systematic Review.甲状腺激素机制改变在与脂肪性肝病相关的代谢功能障碍进展中的作用:一项系统综述
Metabolites. 2022 Jul 22;12(8):675. doi: 10.3390/metabo12080675.
3
A zebrafish pparγ gene deletion reveals a protein kinase network associated with defective lipid metabolism.
斑马鱼 pparγ 基因缺失揭示了与脂质代谢缺陷相关的蛋白激酶网络。
Funct Integr Genomics. 2022 Aug;22(4):435-450. doi: 10.1007/s10142-022-00839-7. Epub 2022 Mar 15.
4
Antioxidant and Antisteatotic Activities of Fucoidan Fractions from Marine and Terrestrial Sources.海洋和陆地来源褐藻糖胶级分的抗氧化和抗脂肪变性活性。
Molecules. 2021 Jul 24;26(15):4467. doi: 10.3390/molecules26154467.
5
Antioxidant and Antisteatotic Activities of a New Fucoidan Extracted from Roots Harvested on Lebanese Mountains.从黎巴嫩山脉收获的根中提取的新型褐藻糖胶的抗氧化和抗脂肪变性活性。
Molecules. 2021 Feb 22;26(4):1161. doi: 10.3390/molecules26041161.
6
Synthesis, Photoisomerization, Antioxidant Activity, and Lipid-Lowering Effect of Ferulic Acid and Feruloyl Amides.阿魏酸及其酰基酰胺的合成、光致异构化、抗氧化活性和降血脂作用。
Molecules. 2020 Dec 28;26(1):89. doi: 10.3390/molecules26010089.
7
Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.甲状腺激素及其代谢产物 3,5-二碘-L-甲状腺原氨酸在哺乳动物中的基因组和非基因组作用机制。
Int J Mol Sci. 2020 Jun 10;21(11):4140. doi: 10.3390/ijms21114140.
8
In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis.在脂肪变性细胞中,ATP-柠檬酸裂解酶 mRNA 通过一种帽非依赖性机制进行有效的翻译,有助于刺激从头合成脂肪。
Int J Mol Sci. 2020 Feb 11;21(4):1206. doi: 10.3390/ijms21041206.
9
A Thyroid Hormone-Independent Molecular Fingerprint of 3,5-Diiodothyronine Suggests a Strong Relationship with Coffee Metabolism in Humans.3,5-二碘甲状腺原氨酸的甲状腺激素非依赖性分子特征表明其与人的咖啡代谢关系密切。
Thyroid. 2019 Dec;29(12):1743-1754. doi: 10.1089/thy.2018.0549. Epub 2019 Nov 11.
10
Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.非酒精性脂肪性肝病与高胆固醇血症:甲状腺激素、代谢物和激动剂的作用。
Thyroid. 2019 Sep;29(9):1173-1191. doi: 10.1089/thy.2018.0664.